Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Belgian Lung Function Study: Personalised Longitudinal Lung Function Analysis as a Marker of Disease Progression

NCT07419555 is registered in ClinicalTrials.gov with KU Leuven as lead sponsor.

NCT NCT07419555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07419555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Belgian Lung Function Study: Personalised Longitudinal Lung Function Analysis as a Marker of Disease Progression
Lead sponsor
KU Leuven
Phase
Observational
Overall status
Recruiting
Start date
March 25, 2026
Completion date
March 1, 2029
Enrollment
5,000 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

chronic respiratory diseases